Bayesian Health

Bayesian Health builds a real-time clinical intelligence platform that reads patient records continuously and surfaces only the patients who need attention — most notably for sepsis, deterioration, readmission risk, and palliative care. The company recently received FDA clearance for continuous AI sepsis monitoring, and a 5-site study in Nature Medicine showed reductions in mortality and length of stay along with 89% clinician adoption. Founded by Dr. Suchi Saria out of decades of Johns Hopkins research, Bayesian sells to health systems and is backed by Andreessen Horowitz. The team is small and research-driven, with values centered on tackling hard clinical problems and clear, evidence-led communication.